PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 122 filers reported holding PMV PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $101,519 | -10.8% | 16,534 | -9.1% | 0.06% | -7.5% |
| Q2 2023 | $113,832 | +129.0% | 18,184 | +74.5% | 0.07% | +148.1% |
| Q1 2023 | $49,713 | -60.4% | 10,422 | -27.8% | 0.03% | -59.1% |
| Q4 2022 | $125,498 | -4.9% | 14,425 | +30.4% | 0.07% | +24.5% |
| Q3 2022 | $132,000 | -15.9% | 11,061 | +0.7% | 0.05% | -8.6% |
| Q2 2022 | $157,000 | +12.1% | 10,986 | +62.9% | 0.06% | -7.9% |
| Q1 2022 | $140,000 | -15.2% | 6,746 | -5.7% | 0.06% | +1.6% |
| Q4 2021 | $165,000 | -11.3% | 7,151 | +14.8% | 0.06% | -24.4% |
| Q3 2021 | $186,000 | -17.0% | 6,229 | -5.0% | 0.08% | -10.9% |
| Q2 2021 | $224,000 | – | 6,556 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $9,915,554 | 48.05% |
| OUP Management Co., LLC | 989,232 | $6,073,884 | 13.66% |
| Euclidean Capital LLC | 5,255,286 | $32,267,456 | 3.52% |
| Tri Locum Partners LP | 821,384 | $5,043,298 | 1.61% |
| Ghost Tree Capital, LLC | 705,881 | $4,334,109 | 1.42% |
| Boxer Capital, LLC | 3,163,795 | $19,425,701 | 1.03% |
| Mesirow Financial Investment Management, Inc. | 34,748 | $213,353 | 0.93% |
| Orbimed Advisors | 6,563,077 | $40,297,293 | 0.86% |
| Octagon Capital Advisors LP | 904,000 | $5,550,560 | 0.85% |
| Nextech Invest Ltd. | 421,284 | $2,586,684 | 0.78% |